Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genes and microbes converge in colitis: Both host genetics and intestinal microbes probably contribute to a person's overall susceptibility to inflammatory bowel disease (IBD). The human gut microbe Bacteroides fragilis produces immunomodulatory molecules that it releases via outer membrane vesicles (OMVs). These molecules can protect mice from experimentally induced colitis. Chu et al. now find that OMV-mediated protection from colitis requires Atg16l1 and Nod2 genes whose human orthologs are associated with an increased risk for developing IBD. OMVs trigger an ATG16L1 and NOD2–dependent noncanonical autophagy pathway in dendritic cells (DCs). OMV-primed DCs, in turn, induce regulatory T cells in the intestine that protect against colitis. Science , this issue p. 1116
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“commensal Bacteroides fragilis‐induced activation of LAP drives a transcriptionally tolerogenic program of differentiation in antigen‐presenting cells, which is required to generate immunosuppressive TREG cells in the context of colitis (Chu et al, 2016).”
From Autophagy in major human diseases (2021) · cites this paper as Chu et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 12×
“Data are representative of at least three independent experiments, with three to nine mice per group. a known product of LAP activation (36), but at significantly reduced levels in Nod2−/− or Tlr2−/− DCs (fig.”
BackgroundInfluentialSelf-citationRetractedGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 2×
“published online EpubJan (S0016-5085(11)01378-3 [pii]10.”
Self-citationInteractions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 2×
“Intestinal microbiota modulate development and function of the immune system, and play a critical role in inflammatory bowel disease (IBD), a family of idiopathic intestinal disorders including Crohn’s disease (CD) and ulcerative colitis (UC) (1-6).”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340 · cited 1×
“fragilis capsular Polysaccharide A (PSA) is packaged in outer membrane vesicles (OMVs) and delivered to intestinal dendritic cells to induce interleukin-10 (IL-10) production from CD4+Foxp3+ regulatory T cells (Tregs), which protect from experimental colitis (30-32).”
BackgroundSelf-citation
Cited by
Items 301–400 of 645
Hosomi, S., Yamagami, H., Itani, S., Yukawa, T., Otani, K., Nagami, Y., Tanaka, F., Taira, K., Kamata, N., Tanigawa, T., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx124 · Cited by 29
Autoimmunity in microbiome-mediated diseases and novel therapeutic approaches
Shin, C., & Kim, Y. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.018 · Cited by 30
Jin, X., Li, H., Pan, S., Song, B., Jiang, Y., Shi, H., Zhang, J., Chu, B., Wang, H., & He, Y. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c12139 · Cited by 30
Comparative study on the pathogenesis of Crohn’s disease and ulcerative colitis
Yang, Q., & Zhang, C. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i19.106406 · Cited by 40
“Microbial infections cause inflammation directly or indirectly by a damaged intestinal mucosal barrier, imbalance of microbial homeostasis, as well as altering immune system in IBD[47].”
InfluentialAssessment of oral ciprofloxacin impaired gut barrier integrity on gut bacteria in mice
Zhu, S., Li, H., Liang, J., Lv, C., Zhao, K., Niu, M., Li, Z., Zeng, L., & Xu, K. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106460 · Cited by 30
ATG16L1 negatively regulates RICK/RIP2-mediated innate immune responses
Honjo, H., Watanabe, T., Arai, Y., Kamata, K., Minaga, K., Komeda, Y., Yamashita, K., & Kudo, M. (2020) · International Immunology · doi:10.1093/intimm/dxaa062 · Cited by 28
Sustainable therapies by engineered bacteria
Álvarez, B., & Fernández, L. Á. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12778 · Cited by 32
“…and metabolic diseases Given the extensive use of LAB as probiotics in foods, it is not surprising that early work on engineering therapeutic bacteria involved LAB and diseases of the GIT, like inflammatory bowel diseases (IBDs; Xavier and Podolsky, 2007; Rescigno, 2014; Chu et al., 2016).”
BackgroundNOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation
Anderson, J. M., Lipinski, S., Sommer, F., Pan, W.-H., Boulard, O., Rehman, A., Falk‐Paulsen, M., Stengel, S. T., Aden, K., Häsler, R., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.03.008 · Cited by 29
“Many of the identified genes have been shown to play a role in maintaining intestinal barrier function and potentially are involved in controlling the intestinal microbiota (eg, by affecting levels of antimicrobial peptides, mucus composition, or autophagic clearance of intracellular bacteria).(2) Nucleotide-binding o…”
BackgroundFirst and second generation probiotic therapeutics for Inflammatory Bowel Disease
Sireswar, S., Ghosh, I., & Dey, G. (2019) · PharmaNutrition · doi:10.1016/j.phanu.2019.100159 · Cited by 28
The Role of Hsp70 in the Regulation of Autophagy in Gametogenesis, Pregnancy, and Parturition
Witkin, S. S., Kanninen, T. T., & Sisti, G. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-51409-3_6 · Cited by 31
Wang, Z., Li, Z., Feng, D., Zu, G., Yang, L., Zhao, Y., Wang, G., Ning, S., Zhu, J., Zhang, F., et al. (2018) · Shock · doi:10.1097/shk.0000000000001259 · Cited by 29
“ATG16L1-deficient mice present large quantities of IL-1b and IL-18 in response to LPS or during colitis (18, 31).”
BackgroundAutophagy proteins influence endocytosis for MHC restricted antigen presentation
Münz, C. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.005 · Cited by 28
Chen, H., Li, H., & Liu, Z. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820935188 · Cited by 30
Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice
Zhang, W., Huang, J., Gao, F., You, Q.-L., Ding, L., Gong, J., Zhang, M., Ma, R., Zheng, S., Sun, X., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104323 · Cited by 31
“42,43 Previously, altered gut microorganisms and serious gastrointestinal problems have been reported in ASD patients, 44,45 and transplantation of gut microbiota from human ASD patients has been shown to mediate autism-like abnormal behaviour and neuronal activity in germ-free mice.”
Endocytosis regulation by autophagy proteins in MHC restricted antigen presentation
Keller, C. W., Loi, M., Ligeon, L., Gannagé, M., Lünemann, J. D., & Münz, C. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.014 · Cited by 27
Spalinger, M. R., Schwarzfischer, M., Hering, L., Shawki, A., Sayoc, A., Santos, A. N., Gottier, C., Lang, S., Bäbler, K., Geirnaert, A., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0201-1 · Cited by 27
Amamoto, R., Shimamoto, K., Park, S., Matsumoto, H., Shimizu, K., Katto, M., Tsuji, H., Matsubara, S., Shephard, R. J., & Aoyagi, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-91917-6 · Cited by 26
Pu, D., Zhang, Z., & Feng, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.906419 · Cited by 28
“At the genetic level, variants of NOD2 and ATG16L1, the main risk genes for IBD, cause defects in the innate immunity of the intestine, resulting in alterations in the structure of intestinal microbes and impaired protective function of commensal bacteria, thereby inducing the development of IBD (Chu et al., 2016).”
BackgroundClock Genes, Metabolism, and Cardiovascular Risk
Tarquini, R., & Mazzoccoli, G. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.05.001 · Cited by 27
Liu, Z., Jiang, Y., Fan, Q., Li, S., & Wang, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s540163 · Cited by 28
“Genome-wide association studies (GWAS) have shown that autophagy-related genes are closely linked to IBD, 84 and deletion of intestinal epithelial (IEC) HIF-1α significantly reduces autophagy., resulting in disruption of intestinal barrier integrity and increased susceptibility to dextran sulfate sodium (DSS)-induced…”
InfluentialZhang, M., Zou, X., Zhao, D., Zhao, F., & Li, C. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901105 · Cited by 27
Münz, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868888 · Cited by 31
“In addition, a LAPlike pathway supports bacterial outer membrane vesicle (OMV) processing for the stimulation of regulatory CD4 T cells in the mouse gut (42).”
BackgroundZhang, W., Jin, Z., Yang, Z., Zhang, J., Ma, X., Guan, J. Z., Sun, B., & Chen, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.818111 · Cited by 30
Microbiota: A potential orchestrator of antidiabetic therapy
Liu, B., Zhang, L., Yang, H., Zheng, H., & Liao, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.973624 · Cited by 31
“Dysbiosis of the gut microbiota is associated with the occurrence and development of various diseases, such as immunological diseases (4, 5), inflamed intestinal diseases (6, 7), mental disorders (8, 9), and metabolic diseases (10–13).”
BackgroundWang, X., Yuan, X., Su, Y.-T., Hu, J., Ji, Q., Fu, S., Li, R., Hu, L.-P., & Dai, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696766 · Cited by 26
Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer’s Disease
Choi, H., Lee, D., & Mook‐Jung, I. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215235 · Cited by 24
“In support of this notion, it is known that patients with IBS who share the same risk factor, the bacterial translocation, are also highly susceptible to metabolic disease such as obesity-induced type 2 diabetes [144, 178–180].”
Autophagy Proteins in Viral Exocytosis and Anti-Viral Immune Responses
Münz, C. (2017) · Viruses · doi:10.3390/v9100288 · Cited by 23
“LAP was found to support MHC class II-restricted presentation of phagocytosed antigen to CD4+ helper T cells [10,55,56] and to restrict inflammation at the intestinal mucosa [57,58].”
BackgroundGut-bacteria derived membrane vesicles and host metabolic health: a narrative review
Verbunt, J., Jocken, J. W. E., Blaak, E. E., Savelkoul, P. H. M., & Stassen, F. R. M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2359515 · Cited by 27
Zhao, Y., Zhu, M., Ling, Y., Zhao, Y., Lu, X., Chu, B., He, Y., & Wang, H. (2025) · Advanced Materials · doi:10.1002/adma.202417334 · Cited by 27
Relationships between dietary diversity and gut microbial diversity in the elderly
Amamoto, R., Shimamoto, K., Suwa, T., Park, S., Matsumoto, H., Shimizu, K., Katto, M., Makino, H., Matsubara, S., & Aoyagi, Y. (2022) · Beneficial Microbes · doi:10.3920/bm2022.0054 · Cited by 24
Dietary lactate supplementation can alleviate DSS-induced colitis in piglets
Wang, M., Fan, Z., Chen, D., Yu, B., He, J., Yu, J., Mao, X., Huang, Z., Luo, Y., Luo, J., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114148 · Cited by 22
Cao, Z., Liu, R., Wang, C., Lin, S., Wang, L., & Pang, Y. (2023) · ACS Nano · doi:10.1021/acsnano.2c08780 · Cited by 23
Münz, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.03.005 · Cited by 24
The Role for Exosomal microRNAs in Disruption of Regulatory T Cell Homeostasis in Multiple Sclerosis
Kimura, K., Hohjoh, H., & Yamamura, T. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518764892 · Cited by 25
Ye, H., Wang, H., Han, B., Chen, K., Wang, X., Ma, F., Cheng, L., Zheng, S., Zhao, X., Zhu, J., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156254 · Cited by 22
Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease
Park, Y. M., Ha, E., Gu, K., Shin, G. Y., Lee, C. K., Kim, K.-W., & Kim, H. J. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000213 · Cited by 25
Leng, X.-Y., Yang, J., Fan, H., Chen, Q.-Y., Cheng, B.-J., He, H., Gao, F., Zhu, F., Yu, T., & Liu, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109000 · Cited by 21
The potential role of gut microbiota outer membrane vesicles in colorectal cancer
Meng, R., Zeng, M., Ji, Y., Huang, X., & Xu, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1270158 · Cited by 23
Bacteria-based drug delivery for treating non-oncological diseases
Cao, Z., Pang, Y., Pu, J., & Liu, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.020 · Cited by 25
Nie, S., Zhang, Z., Ji, Y., Ding, Q., Gong, J., Xiao, F., Chen, L., Tian, D., Liu, M., & Luo, Z. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2379633 · Cited by 25
“33 In brief, cellular infiltrates in the mucosa and submucosa were scored 0–4 and 0–3, respectively.”
BackgroundFu, J., Zhao, Z., Zhou, D., & Liu, S. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70400 · Cited by 23
“In addition, PSA is recognized by dendritic cells (DCs) in the intestine and then causes IL-10 production by DC cells, thus promoting Treg production (Chu et al. 2016).”
Immune cells: the key mediator between the gut microbiota and osteoporosis
Ma, T., Zhang, T., Peng, C., Liu, K., Xiong, Y., Chen, K., Peng, N., Wei, Z., Kuang, J., & Ou, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680021 · Cited by 23
Xu, H., Cai, F., Li, P., Wang, X., Yao, Y., Chang, X., Bi, Z., Sun, H., Zhuang, H., & Hua, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.727664 · Cited by 23
“Intestinal Microbial Detection of Four Enteritis Models In recent years, several studies have found that intestinal flora plays an important role in the occurrence and development of enteritis (2, 38, 39).”
BackgroundGu, Z., Meng, S., Wang, Y., Lyu, B., Li, P., & Shang, N. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2039897 · Cited by 20
An exploratory study on the effect of daily fruits and vegetable juice on human gut microbiota
Choi, Y. J., Lee, D. H., Kim, H. S., & Kim, Y.-K. (2018) · Food Science and Biotechnology · doi:10.1007/s10068-018-0372-7 · Cited by 22
TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion
Wang, D., Li, H., Duan, Y.-Y., Han, F., Luo, Y., Mengyao, W., Yang, M.-Y., Zhan, R., Song, J. M., Zhang, H., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.06.011 · Cited by 20
Chen, J., Zhao, J., Cao, Y., Zhang, G., Yang, C., Zhong, J., Huang, W., Zeng, J., & Wu, P. (2019) · BMC Urology · doi:10.1186/s12894-019-0506-0 · Cited by 24
Fan, Y., Wang, Y., Han, X., & Sun, H. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03646-3 · Cited by 22
“Dysbacte-riosis is associated with a plethora of diseases and states within the host, featuring diabetes [14–16], obesity [17], IBD [18–20], cancer [21, 22], cardiovascular diseases [23, 24], and kidney diseases [25], extending beyond gastrointestinal disorders.”
BackgroundGut microbiome in IBD: past, present and the future
Zhang, J., Mak, J. W. Y., & Ng, S. C. (2025) · Gut · doi:10.1136/gutjnl-2025-335626 · Cited by 28
“29 CARD9 modulates composition and function of the gut microbiota and promotes production of tryptophan-derived metabolites, especially aryl hydrocarbon receptor agonists, which are protective against gut inflammation in mice and humans.”
Miao, R., Zhan, S., Hu, X.-T., Yuan, W.-M., Wu, L., Cui, S., & Qu, X. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.03.009 · Cited by 23
Intestinal antiviral signaling is controlled by autophagy gene Epg5 independent of the microbiota
Lee, S., Kalugotla, G., Ingle, H., Rodgers, R., Wu, C., Wang, Y., Li, Y., Yang, X., Zhang, J., Borella, N. R., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1968607 · Cited by 21
“While autophagy-deficient mice and cells have been reported to fail to appropriately sense and respond to immunomodulatory products from commensal bacteria, thereby leading to colitis [23], the recent observation that autophagy proteins prevent spontaneous type I interferon responses driven by the microbiota in the in…”
BackgroundZhao, S., Wu, J., He, Z., Song, Y., Chang, X., Xia, T., Xue, F., Li, Z., Xu, C., Wang, S., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00767-8 · Cited by 18
“In the digestive system, it was previously demonstrated that baseline autophagy is crucial for the maintenance of intestinal homeostasis, and autophagy dysfunction may play a role in the onset and aggravation of IBD [27, 28].”
BackgroundAutophagy in PDGFRα+ mesenchymal cells is essential for intestinal stem cell survival
Yang, Y., Gomez-Jenkins, M., Marsh, T., Poillet-Perez, L., Sawant, A., Chen, L., Park, N. R., Jackson, S. R., Hu, Z. S., Alon, N., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202016119 · Cited by 24
“Failure to maintain PMCs through autophagy may therefore contribute to IBD. autophagy j intestine j stem cells j IBD j metabolism The autophagy pathway directs the formation of double-membrane-bound vesicles called autophagosomes that capture cargo such as cytoplasmic proteins, organelles, and bacteria.”
BackgroundInfluentialMicrobial Components and Effector Molecules in T Helper Cell Differentiation and Function
Lee, C., Lee, H., Park, J. C., & Im, S. (2023) · Immune Network · doi:10.4110/in.2023.23.e7 · Cited by 21
“fragilis-mediated protective regulation (95).”
BackgroundInfluentialWu, S., Wang, J., Zhu, L., Ren, H., & Yang, X. (2020) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-020-00462-1 · Cited by 18
Intestinal dysbiosis in pediatric Crohn's disease patients with IL10RA mutations
Xue, A., Miao, S., Sun, H., Qiu, X., Wang, S., Wang, L., Ye, Z., Zheng, C., Huang, Z., Wang, Y., et al. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i22.3098 · Cited by 20
Münz, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02765 · Cited by 19
“regulatory CD4 T cells are also less well-induced in mice with Atg16L1 deficiency in dendritic cells and some macrophage compartments (44).”
Wu, J., Li, M., Zhou, C., Rong, J., Zhang, F., Wen, Y., Qu, J., Wu, R. J., Miao, Y., & Niu, J. (2024) · Clinical Proteomics · doi:10.1186/s12014-024-09513-5 · Cited by 21
Niu, S., & Zhang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1620138 · Cited by 21
Bacterial membrane vesicles in inflammatory bowel disease
Shen, Q., Xu, B., Wang, C., Xiao, Y., & Jin, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120803 · Cited by 18
Immunity orchestrates a bridge in gut-brain axis of neurodegenerative diseases
Cheng, Y., Chen, C., & Zhang, F. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101857 · Cited by 21
Protective role of circRNA CCND1 in ulcerative colitis via miR-142-5p/NCOA3 axis
Xiang, P., Ge, T., Zhou, J., & Zhang, Y. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02641-6 · Cited by 17
“Despite treatment efforts, the etiology and pathogenesis of UC remain unclear [2, 3].”
Yang, C., Zhu, J., Bai, J., Zhang, J., Wu, Z., Li, X., Tong, P., Chen, H., & Yang, A. (2023) · Foods · doi:10.3390/foods12030627 · Cited by 17
“DCs can regulate intestinal immune tolerance by promoting the differentiation of CD4+ T cells to Tregs and activating Tregs through a non-classical autophagic pathway [40].”
Kang, M., Feng, K., Dai, W., Miao, J., Liu, G., Fang, H., & Cao, Y. (2023) · Food & Function · doi:10.1039/d2fo03755f · Cited by 17
Probiotic Bacillus licheniformis ZW3 Alleviates DSS-Induced Colitis and Enhances Gut Homeostasis
Jia, D. T., Li, Y., Wang, Y., Guo, Y., Liu, J., Zhao, S., Wang, J., Guan, G., Luo, J., Yin, H., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010561 · Cited by 17
“As a major fraction of the gut bacteriome, the Bacteroidetes phylum is determined to be the only sphingolipid producer among intestinal symbionts, which is essential for maintaining intestinal homeostasis and symbiosis [38,39].”
BackgroundYin-Yang: two sides of extracellular vesicles in inflammatory diseases
Zeng, B., Li, Y., Khan, N., Su, A., Yang, Y., Mi, P., Jiang, B., Liang, Y., & Duan, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02779-9 · Cited by 18
Cheng, Y., Zhu, Z., Yang, Z., Liu, X., Qian, X., Zhu, J., Hu, X., Jiang, P., Cui, T., Wang, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-97369-6 · Cited by 24
“Bacteroides , known for its health-promoting effects such as enhancing pathogen resistance and influencing physiology, metabolism, and immune system development 58–60 , is increasingly recognized for its positive Fig.”
de Souza, P. R., Guimarães, F. R., Sales‐Campos, H., Bonfá, G., Nardini, V., Chica, J. E. L., Turato, W. M., Silva, J. S., Zamboni, D. S., & Cardoso, C. R. D. B. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.07.003 · Cited by 17
Emergent Behavior of IBD-AssociatedEscherichia coliDuring Disease
Renouf, M. J. D., Cho, Y. H., & McPhee, J. B. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy312 · Cited by 18
Engineered bacterial extracellular vesicles for gastrointestinal diseases
Nie, X., Li, Q., He, Y., Xu, Y., Qiao, S., Wang, X., Meng, F., Xie, J., & Nie, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113972 · Cited by 23
Mărginean, C. O., Meliţ, L. E., & Săsăran, M. O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153258 · Cited by 19
“Additionally, it was emphasized that certain commensal intestinal bacteria have the ability to induce the differentiation of these T regulatory cells locally by elaborating several products like short chain fatty acids [94,95], and capsular polysaccharides [96,97].”
BackgroundZhu, C., Wang, X., Li, J., Jiang, R., Chen, H., Chen, T., & Yang, Y. (2022) · BMC Microbiology · doi:10.1186/s12866-021-02414-9 · Cited by 18
“Adding gut microbiota showed no effect on association strengths with Diabetes and IBS 192 DI and IBS are widely reported to be closely related to gut microbes and some diet 193 habits (3, 23); therefore, we hypothesized that adding microbes into human variables will 194 improve the classification of these two conditio…”
BackgroundGao, S., Li, Y., Wu, D., Jiao, N., Li, Y., Zhao, R., Xu, Z., Chen, W., Lin, X., Cheng, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.869200 · Cited by 18
“For instance, some studies reported that the deficiencies in susceptibility genes NOD2 and ATG16L1 may contribute to the IBD risk, due to the impaired anti-inflammatory responses and the further defects in microbial clearance (Chu et al., 2016).”
BackgroundExercise‐induced β‐hydroxybutyrate promotes Treg cell differentiation to ameliorate colitis in mice
Hao, F., Tian, M., Wang, H., Li, S., Wang, X., Jin, X., Wang, Y., Jiao, Y., & Tian, M. (2024) · The FASEB Journal · doi:10.1096/fj.202301686rr · Cited by 20
Extracellular vesicles in Inter-Kingdom communication in gastrointestinal cancer.
Chen, Y., Xu, Y., Zhong, H., Yuan, H., Liang, F., Liu, J., & Tang, W. (2021) · American Journal of Cancer Research · Cited by 23
Wu, Z., & Wang, H. X. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0033-4 · Cited by 22
“PSA can also correct systemic T cell defects, TH1/TH2 imbalance, and guide the occurrence of lymphoid tissue [65].”
BackgroundIntestinal microbiota modulates adrenomedullary response through Nod1 sensing in chromaffin cells
Xiang, C., Chen, P., Zhang, Q., Li, Y., Pan, Y., Xie, W., Sun, J., & Liu, Z. (2021) · iScience · doi:10.1016/j.isci.2021.102849 · Cited by 15
Pan, L., Feng, R., Hu, J., Yu, H., Tong, Q., Yang, X., Song, J., Xu, H. X., Ye, M., Zhang, Z., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.009 · Cited by 15
“Bacteroides fragilis has been re-ported to regulate host immune function by releasing outer membrane vesicles, delivering the immunomodulatory polysaccharide A to immune cells, and inducing the production of IL-10 51 .”
Bacterial subversion of NLR-mediated immune responses
Kienes, I., Johnston, E. L., Bitto, N. J., Kaparakis‐Liaskos, M., & Kufer, T. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.930882 · Cited by 16
“In contrast to pathogen derived BMVs, commensal derived BMVs produced by the commensal gut bacterium Bacteroides fragilis, downregulated the production of the anti-inflammatory cytokine IL-10 by NOD2 knockout murine bone marrow-derived dendritic cells (BMDCs) (76).”
BackgroundHighlights on two decades with microbiota and inflammatory bowel disease from etiology to therapy
Hussein, I. H., Dosh, L., Qassab, M. A., Jurjus, R. A., Masri, J. E., Nader, C. A., Rappa, F., Leone, A., & Jurjus, A. R. (2023) · Transplant Immunology · doi:10.1016/j.trim.2023.101835 · Cited by 19
Ye, X., Liu, Z., Han, H. W., Noh, J. Y., Shen, Z., Kim, D.-M., Wang, H., Guo, H., Ballard, J. L., Golovko, A., et al. (2023) · Genes · doi:10.3390/genes14071455 · Cited by 16
Host gene–microbiome interactions: molecular mechanisms in inflammatory bowel disease
Chu, H. (2017) · Genome Medicine · doi:10.1186/s13073-017-0459-4 · Cited by 19
“Mouse dendritic cells deficient in either Atg16l1 or Nod2 were unable to induce regulatory T-cell responses to suppress mucosal inflammation upon treatment with Bacteroides fragilis, both in vitro and during experimental colitis [10].”
Self-citationMitchell, J., Kim, S. J., Κούκος, Γ., Seelmann, A., Veit, B., Shepard, B., Blumer‐Schuette, S. E., Winter, H. S., Iliopoulos, D., Pothoulakis, C., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy124 · Cited by 15
Iron Supplementation Eliminates Antagonistic Interactions Between Root-Associated Bacteria
Eng, T., Herbert, R. A., Martinez, U., Wang, B., Chen Joseph, C., Brown, J. B., Deutschbauer, A. M., Bissell, M. J., Mortimer, J. C., & Mukhopadhyay, A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01742 · Cited by 21
“, the gut microbiome) (Chu et al., 2016) or crop productivity (e.”
BackgroundProgress in Our Understanding of the Gut Microbiome: Implications for the Clinician
Iqbal, S., & Quigley, E. M. M. (2016) · Current Gastroenterology Reports · doi:10.1007/s11894-016-0524-y · Cited by 20
Flavonoids as modulators of gut-liver axis: emerging therapeutic strategies for MAFLD
Hao, M., Wang, Z., Wang, L., Yimamu, A., Su, X., Zhang, M., Li, X., Zhang, Q., & Sun, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1657751 · Cited by 17
Autophagic degradation of PML promotes susceptibility to HSV-1 by stress-induced Corticosterone
Li, W., Luo, Z., Yan, C., Wang, X., He, Z.-J., Ouyang, S., Yan, C., Liu, L., Zhou, Q., Mu, H.-L., et al. (2020) · Theranostics · doi:10.7150/thno.46921 · Cited by 14
“However, NCA might inhibit intracellular pathogen replication [74, 75] or suppress immune reactions [76].”
BackgroundLongitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis
Volkmann, E. R., Hoffmann‐Vold, A., Chang, Y., Lagishetty, V., Clements, P. J., Midtvedt, Ø., Molberg, Ø., Braun, J. G., & Jacobs, J. P. (2020) · European Medical Journal · doi:10.33590/emj/20-00043 · Cited by 14
Schroeter, C. B., Huntemann, N., Böck, S., Nelke, C., Kremer, D., Pfeffer, K., Meuth, S. G., & Ruck, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.747143 · Cited by 16
Nano-armor modification of bacteria through supramolecular interactions for disease treatment
Cao, X., Wang, Y., Wang, Q., Huang, Y., Ding, Y., & Mao, Z. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216165 · Cited by 15
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
Spanu, D., Pretta, A., Lai, E., Persano, M., Donisi, C., Mariani, S., Dubois, M., Migliari, M., Saba, G., Ziranu, P., et al. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1319 · Cited by 17
Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics
Stylianou, E. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0298-4 · Cited by 15
Yang, Y., Xu, L., Li, Y., Sun, Y., Tang, Y., Xiao, Z., Li, M., Chen, Y., Wang, Y., & Shen, X. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70194 · Cited by 16
Demoruelle, M. K. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.04.012 · Cited by 13
Okai, N., Watanabe, T., Minaga, K., Kamata, K., Honjo, H., & Kudo, M. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i26.3063 · Cited by 17
Wang, Y., Huang, L., Huang, T., Geng, S., Chen, X., Huang, X., Lai, P., Du, X., & Weng, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.813576 · Cited by 16
“, 2016), inflammatory bowel disease (IBD) (Chu et al., 2016), type 1 diabetes (Forbes et al.”
BackgroundJiang, N., Xiao, Y., Yuan, K., & Wang, Z. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16129 · Cited by 13
Liu, C., Shi, J., Wang, J., Dai, Y., & Raghavan, V. (2023) · Food Research International · doi:10.1016/j.foodres.2023.113398 · Cited by 16
Microbe-host interactions: structure and functions of Gram-negative bacterial membrane vesicles
Xiao, M., Li, G., & Yang, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1225513 · Cited by 14
Seo, Y.-J., Lim, C., Lim, B., & Kim, J. (2024) · Animal Biotechnology · doi:10.1080/10495398.2024.2331179 · Cited by 13
“22,23 In recent observations, the microbiome directly affected stress-associated hormones and mediators in bacterial pathogens.”
Metadata
- Authors
- Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., Targan, S. R., Xavier, R. J., Ernst, P. B., Green, D. R., McGovern, D. P. B., Virgin, H. W., & Mazmanian, S. K.
- Affiliations
- California Institute of Technology (US)
- University of California San Diego (US)
- St. Jude Children's Research Hospital (US)
- Washington University in St. Louis (US)
- Cedars-Sinai Medical Center (US)
- Harvard University (US)
- Corresponding author
- Chu, Hiutung
- Mazmanian, Sarkis K.
- ORCID
- Venue
- Science
- Published
- 2016-05-27
- Volume
- 352
- Issue
- 6289
- Pages
- 1116-1120
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4996125
- OpenAlex
- W2346233234
- Cited by
- 647
- References
- 48
- Citations by year
- 2026: 50 · 2025: 55 · 2024: 60 · 2023: 64 · 2022: 57 · 2021: 69 · 2020: 68 · 2019: 77 · 2018: 56 · 2017: 65 · 2016: 24
- FWCI
- 59.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH)
- Ruth L. Kirschtein National Research Service Award (DK100109)
- Cedars-Sinai F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute Research Funds
- Feintech Family Chair
- Wayne and Gladys Valley Foundation
- Lupus Research Institute
- Lisa Z. Greer Endowed Chair
- European Union (305479)
- Leona M. and Harry B. Helmsley Charitable Trust
- NIH (DK097485, PO1DK046763, AI079145, AI40646, U19 AI109725, DK062413, DE023789-01, AI109725, DK078938, GM099535)
- Crohn's and Colitis Foundation of America
- Heritage Medical Research Institute
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- inflammatory bowel disease, Bacteroides fragilis, outer membrane vesicles, ATG16L1, NOD2, non-canonical autophagy, dendritic cells, regulatory T cells, colitis, gut dysbiosis, susceptibility genes, mucosal inflammation
- MeSH terms
- Extracellular Vesicles, Gastrointestinal Microbiome, Autophagy-Related Proteins, Adult, Aged, Animals, Autophagy, Bacteroides fragilis, Carrier Proteins, Dendritic Cells, Female, Humans, Intestinal Mucosa, Male, Mice, Inbred C57BL, Middle Aged, Polymorphism, Genetic, Inflammatory Bowel Diseases, Genome, Human, Genetic Predisposition to Disease, T-Lymphocytes, Regulatory, Mice, Nod2 Signaling Adaptor Protein, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.